Berezina TA - Search Results

1

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.

Berezin AA, Obradovic Z, Fushtey IM, Berezina TA, Novikov EV, Schmidbauer L, Lichtenauer M, Berezin AE. Berezin AA, et al. Among authors: berezina ta. Biomedicines. 2023 Feb 4;11(2):457. doi: 10.3390/biomedicines11020457. Biomedicines. 2023. PMID: 36830993 Free PMC article.

2

The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation.

Berezin AA, Obradovic Z, Kopp K, Berezina TA, Lichtenauer M, Wernly B, Berezin AE. Berezin AA, et al. Among authors: berezina ta. Int J Mol Sci. 2022 Dec 31;24(1):729. doi: 10.3390/ijms24010729. Int J Mol Sci. 2022. PMID: 36614172 Free PMC article.

3

Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines.

Berezin AA, Obradovic Z, Berezina TA, Boxhammer E, Lichtenauer M, Berezin AE. Berezin AA, et al. Among authors: berezina ta. Antioxidants (Basel). 2023 Feb 17;12(2):516. doi: 10.3390/antiox12020516. Antioxidants (Basel). 2023. PMID: 36830074 Free PMC article. Review.

4

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure.

Berezina TA, Obradovic Z, Boxhammer E, Berezin AA, Lichtenauer M, Berezin AE. Berezina TA, et al. J Clin Med. 2023 Mar 13;12(6):2231. doi: 10.3390/jcm12062231. J Clin Med. 2023. PMID: 36983232 Free PMC article.

5

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure.

Berezin AA, Obradovic AB, Fushtey IM, Berezina TA, Lichtenauer M, Berezin AE. Berezin AA, et al. Among authors: berezina ta. J Cardiovasc Dev Dis. 2023 Mar 23;10(4):136. doi: 10.3390/jcdd10040136. J Cardiovasc Dev Dis. 2023. PMID: 37103015 Free PMC article.

6

Cell-free DNA as a plausible biomarker of chronic kidney disease.

Berezina TA, Berezin AE. Berezina TA, et al. Epigenomics. 2023 Sep;15(17):879-890. doi: 10.2217/epi-2023-0255. Epub 2023 Oct 4. Epigenomics. 2023. PMID: 37791402 Review.

7

Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure.

Berezina TA, Fushtey IM, Berezin AA, Pavlov SV, Berezin AE. Berezina TA, et al. Adv Ther. 2024 Jan;41(1):292-314. doi: 10.1007/s12325-023-02683-y. Epub 2023 Nov 8. Adv Ther. 2024. PMID: 37935870 Free PMC article.

8

Plausible prediction of renoprotective effects of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney diseases.

Berezin AE, Berezina TA. Berezin AE, et al. Among authors: berezina ta. J Int Med Res. 2024 Feb;52(2):3000605241227659. doi: 10.1177/03000605241227659. J Int Med Res. 2024. PMID: 38329077 Free PMC article. Review.

9

Methods to predict heart failure in diabetes patients.

Berezin AE, Berezina TA, Hoppe UC, Lichtenauer M, Berezin AA. Berezin AE, et al. Among authors: berezina ta. Expert Rev Endocrinol Metab. 2024 May;19(3):241-256. doi: 10.1080/17446651.2024.2342812. Epub 2024 Apr 15. Expert Rev Endocrinol Metab. 2024. PMID: 38622891 Review.

10

An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney disease.

Berezin AE, Berezina TA, Hoppe UC, Lichtenauer M, Berezin AA. Berezin AE, et al. Among authors: berezina ta. Expert Rev Mol Diagn. 2024 Jul;24(7):627-647. doi: 10.1080/14737159.2024.2379355. Epub 2024 Jul 15. Expert Rev Mol Diagn. 2024. PMID: 39007888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters